Detalhe da pesquisa
1.
B-Cell-Specific Diversion of Glucose Carbon Utilization Reveals a Unique Vulnerability in B Cell Malignancies.
Cell;
173(2): 470-484.e18, 2018 04 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29551267
2.
Asciminib in Newly Diagnosed Chronic Myeloid Leukemia.
N Engl J Med;
2024 May 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38820078
3.
Splicing factor YBX1 mediates persistence of JAK2-mutated neoplasms.
Nature;
588(7836): 157-163, 2020 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33239784
4.
Aleukemic Chronic Myeloid Leukemia Without Neutrophilia and Thrombocytosis: A Report From the BCR::ABL1 Pathology Group.
Mod Pathol;
37(2): 100406, 2024 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38104892
5.
PLCG1 is required for AML1-ETO leukemia stem cell self-renewal.
Blood;
139(7): 1080-1097, 2022 02 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34695195
6.
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
Blood;
139(1): 87-103, 2022 01 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34320176
7.
Treatment of chronic-phase chronic myeloid leukemia in patients randomized to dasatinib or imatinib after suboptimal responses to three months of imatinib therapy: final 5-year results from DASCERN.
Haematologica;
2024 May 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38695123
8.
Time from diagnosis to treatment has no impact on survival in newly diagnosed acute myeloid leukemia treated with venetoclax-based regimens.
Haematologica;
2024 Apr 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38654660
9.
Author Correction: Metabolic gatekeeper function of B-lymphoid transcription factors.
Nature;
558(7711): E5, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29849140
10.
Immunoproteasome function maintains oncogenic gene expression in KMT2A-complex driven leukemia.
Mol Cancer;
22(1): 196, 2023 12 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38049829
11.
Molecular-defined clonal evolution in patients with classical myeloproliferative neoplasms.
Br J Haematol;
202(2): 308-317, 2023 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37139709
12.
Outcomes after allogeneic haematopoietic stem cell transplantation in young adults in Germany.
Br J Haematol;
201(2): 308-318, 2023 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36573337
13.
Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: a randomized, open-label phase 2 clinical trial.
Blood;
138(21): 2042-2050, 2021 11 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34407543
14.
A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs.
Blood;
138(21): 2031-2041, 2021 11 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34407542
15.
Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis.
Haematologica;
108(6): 1567-1578, 2023 06 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36727397
16.
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
Ann Hematol;
102(2): 349-358, 2023 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36564535
17.
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
Ann Hematol;
102(10): 2741-2752, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37592092
18.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Ann Hematol;
102(3): 547-561, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36695874
19.
Isolation of Hafnia paralvei co-harbouring blaNDM-1 and blaVIM-1 in a woman who underwent allogeneic hematopoietic stem cell transplantation.
Infection;
51(4): 1161-1164, 2023 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36595211
20.
Metabolic gatekeeper function of B-lymphoid transcription factors.
Nature;
542(7642): 479-483, 2017 02 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28192788